Company Profiles

driven by the PitchBook Platform

Aset Therapeutics

Description

Developer of novel therapeutics designed to treat splice-activated oncogenes. The company's novel therapeutics offers precision medicines that helps oncologists to screen cancer patients for tumors driven by splice-activated-oncogenes and prescribe selective treatments and generates therapeutic agents that inhibit aberrant isoforms, enabling doctors to treat brain tumors and non small cell lung cancer.

2016

Founded

PRIVATE

Status

Angel

Latest Deal Type

$7.1M

Latest Deal Amount

$7.13M

Total Amount Raised

2

Investors

Description

Developer of novel therapeutics designed to treat splice-activated oncogenes. The company's novel therapeutics offers precision medicines that helps oncologists to screen cancer patients for tumors driven by splice-activated-oncogenes and prescribe selective treatments and generates therapeutic agents that inhibit aberrant isoforms, enabling doctors to treat brain tumors and non small cell lung cancer.

Ownership Status

Privately Held (backing)

Financing Status

Accelerator/Incubator Backed

Primary Industry

Biotechnology

Other Industries

Drug Discovery

Primary Office

25 Health Sciences Drive Stony Brook, NY 11790United States +1 (212) 692-6810
    Request a free trial to the PitchBook Platform
    You're viewing a free company profile from the PitchBook Platform. To explore Aset Therapeutics's full profile, request a free trial.

    Aset Therapeutics Valuation and Funding

    Request access
    Deal TypeDateAmountRaised to DatePost-ValStatusStage

    Aset Therapeutics Investors (2)

    Request access
    Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
    Seat
    Contact
    Info
    Long Island High Technology IncubatorAccelerator/IncubatorMinority000 0000000 0000
    Start-up NYAccelerator/Incubator000 0000000 0000
    Long Island High Technology Incubator Accelerator/Incubator
    Start-up NY Accelerator/Incubator

    Aset Therapeutics Executive Team (3)

    NameTitleBoard
    Seat
    Contact
    Info
    David EpsteinPresident, Chief Executive Officer & Board Member
    Elizabeth Buck Ph.DChief Scientific Officer & Chief Operating Officer
    Alexander MaywegExecutive Director & Board Member
    David Epstein President, Chief Executive Officer & Board Member
    Elizabeth Buck Ph.D Chief Scientific Officer & Chief Operating Officer
    Alexander Mayweg Executive Director & Board Member

    Aset Therapeutics Board Members (2)

    NameRepresentingRoleSinceContact
    Info
    Alexander MaywegAset TherapeuticsExecutive Director & Board Member000 0000
    Garry MenzelAset TherapeuticsBoard Member000 0000
    Alexander Mayweg Executive Director & Board Member Aset Therapeutics
    Garry Menzel Board Member Aset Therapeutics
    Request full access to PitchBook